Clinical Trial Update: Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.

View source ↗

Summary

The study evaluates the COGNISION handheld ERP/qEEG system as a potential cognitive biomarker for Alzheimer's disease. The trial by Neuronetrix, Inc. is listed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Dementia
• Frontotemporal Dementia
• Memory Disorders

Snippet

Sponsor: Neuronetrix, Inc. | Conditions: Memory Disorders, Alzheimer Disease | Status: COMPLETED